Search results
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the...
Fortune via Yahoo Finance UK· 7 days agoSix months later, COVID appeared in China, and a little later, all over the world. In those early...
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 22 hours agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
Reuters· 2 days ago, opens new tab to a lawsuit accusing them of illegally helping to fund terrorism that killed or...
5 Fidelity Mutual Funds to Buy for Long-Term Gains
Zacks via Yahoo Finance UK· 6 days agoInvest in Fidelity mutual funds like FIKGX, FIKAX, FSPCX, FSUTX and FPHAX, which have given impressive returns this year and are expected to perform well...
I just put £4k into my SIPP. Here’s where I’m going to invest it
Motley Fool UK· 5 days agoInvesting in a SIPP (Self-Invested Personal Pension) is one of the best ways to build wealth for...
Small-Molecule Price Controls Are Short-Sighted
Forbes· 3 days agoThe combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over the...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
Daily Telegraph· 2 days agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters· 3 days agoG1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial.
'I quit teaching after 35 years to become a magician - I've never been happier'
Manchester Evening News via Yahoo News UK· 6 days agoHe regularly performs at weddings, stag dos, birthdays and corporate Christmas parties – some of his...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance UK· 6 days agoJ&J faces the upcoming patent expiration of Stelara in 2025 and talc litigations. AbbVie, Merck,...